Expanding health care coverage in Canada: a dramatic shift in the debate

Area of Science:

• Health Policy
• Canadian Healthcare System
• Public Health

Background:

• The COVID-19 pandemic significantly altered Canada's health policy landscape.
• Pre-pandemic discussions focused on outpatient pharmaceuticals; pandemic deaths in long-term care (LTC) shifted focus to federal LTC standards.
• This has created an opportunity to expand universal health coverage (medicare) for the first time in over 50 years.

Purpose of the Study:

• To analyze the impact of the COVID-19 pandemic on Canadian health policy debates.
• To propose alternative federal pathways for expanding universal health coverage to include long-term care and outpatient pharmaceuticals.
• To assess the feasibility of these proposals within the current Canadian federal structure.

Main Methods:

• Policy analysis of the Canadian health system.
• Review of government reports and expert discussions on health policy.
• Examination of federal-provincial fiscal arrangements and their historical impact on medicare expansion.

Main Results:

• The pandemic has intensified calls for federal involvement in long-term care and outpatient pharmaceuticals.
• Traditional shared-cost federalism models used for medicare expansion are unlikely to succeed in the current political climate.
• Two distinct alternative pathways are proposed for LTC and pharmaceuticals, respectively.

Conclusions:

• Expanding medicare to include long-term care and outpatient pharmaceuticals is a key policy challenge for Canada.
• Successful expansion requires innovative federal approaches that move beyond historical shared-cost models.
• The proposed alternative pathways offer a more viable strategy for achieving comprehensive universal health coverage in Canada.